- Home
- DGX vs DKNG Comparison
DGX vs DKNG Comparison
Compare DGX & DKNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGX
- DKNG
- Stock Information
- Founded
- DGX 1967
- DKNG N/A
- Country
- DGX United States
- DKNG United States
- Employees
- DGX N/A
- DKNG N/A
- Industry
- DGX Medical Specialities
- DKNG Services-Misc. Amusement & Recreation
- Sector
- DGX Health Care
- DKNG Consumer Discretionary
- Exchange
- DGX Nasdaq
- DKNG Nasdaq
- Market Cap
- DGX 20.5B
- DKNG 23.8B
- IPO Year
- DGX 1996
- DKNG N/A
- Fundamental
- Price
- DGX $186.08
- DKNG $28.65
- Analyst Decision
- DGX Buy
- DKNG Strong Buy
- Analyst Count
- DGX 15
- DKNG 27
- Target Price
- DGX $194.07
- DKNG $48.33
- AVG Volume (30 Days)
- DGX 1.2M
- DKNG 20.8M
- Earning Date
- DGX 10-21-2025
- DKNG 11-06-2025
- Dividend Yield
- DGX 1.72%
- DKNG N/A
- EPS Growth
- DGX 14.49
- DKNG N/A
- EPS
- DGX 8.51
- DKNG N/A
- Revenue
- DGX $10,850,000,000.00
- DKNG $5,458,104,000.00
- Revenue This Year
- DGX $12.37
- DKNG $33.29
- Revenue Next Year
- DGX $3.51
- DKNG $20.08
- P/E Ratio
- DGX $21.86
- DKNG N/A
- Revenue Growth
- DGX 13.74
- DKNG 18.50
- 52 Week Low
- DGX $148.70
- DKNG $26.23
- 52 Week High
- DGX $197.55
- DKNG $53.61
- Technical
- Relative Strength Index (RSI)
- DGX 57.00
- DKNG 34.60
- Support Level
- DGX $184.50
- DKNG $29.93
- Resistance Level
- DGX $190.47
- DKNG $32.03
- Average True Range (ATR)
- DGX 4.28
- DKNG 1.36
- MACD
- DGX 1.02
- DKNG 0.25
- Stochastic Oscillator
- DGX 70.37
- DKNG 44.09
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About DKNG DraftKings Inc.
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number two or three revenue share position across states in which it competes. DraftKings is now live with online or retail sports betting in 28 states and iGaming in five states, with both products available to around 40% of Canada's population. In 2024, sports revenue was 61% of total sales, i-gaming 32%, and fantasy and lottery 7%. The company also operates a non-fungible token commissioned-based marketplace and develops and licenses online gaming products.